Tadalafil
Adcirca, Cialis, Tadalafil Lilly (tadalafil) is a small molecule pharmaceutical. Tadalafil was first approved as Adcirca on 2002-11-12. It is used to treat pulmonary hypertension and vasculogenic impotence in the USA. It has been approved in Europe to treat erectile dysfunction and pulmonary hypertension. The pharmaceutical is active against cGMP-specific 3',5'-cyclic phosphodiesterase. In addition, it is known to target dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A.
| Trade Name | Adcirca, Cialis, Tadalafil Lilly, Tadalafil Lilly |
|---|---|
| Common Name | Tadalafil |
| Indication | erectile dysfunction, pulmonary hypertension, vasculogenic impotence |
| Drug Class | Pde5 inhibitors |
